Safety of Hormone Replacement Therapy (HRT) in Systemic Lupus Erythematosus (SLE)
暂无分享,去创建一个
T. Spector | G. Hughes | N. Arden | N. Arden | M. Lloyd | M. E. Lloyd | G. Hughes | T. Spector
[1] Ø. Lidegaard,et al. Oral contraception and risk of a cerebral thromboembolic attack: results of a case-control study. , 1993, BMJ.
[2] M. Petri,et al. Risk factors for coronary artery disease in patients with systemic lupus erythematosus. , 1992, The American journal of medicine.
[3] L. Melton,et al. The prevention and treatment of osteoporosis. , 1992, The New England journal of medicine.
[4] E. Barrett-Connor,et al. Estrogen replacement therapy and the risk of venous thrombosis. , 1992, The American journal of medicine.
[5] J. Manson,et al. Postmenopausal estrogen therapy and cardiovascular disease. Ten-year follow-up from the nurses' health study. , 1991, The New England journal of medicine.
[6] I. Cohen,et al. [Postmenopausal estrogen therapy and cardiovascular disease]. , 1991, Harefuah.
[7] H. Julkunen. Oral contraceptives in systemic lupus erythematosus: side-effects and influence on the activity of SLE. , 1991, Scandinavian journal of rheumatology.
[8] Š. Alušík,et al. [The anti-cardiolipin syndrome]. , 1988, Vnitrni lekarstvi.
[9] V. Ravnikar. Compliance with hormone therapy. , 1987, American journal of obstetrics and gynecology.
[10] M. Snaith,et al. Oestrogen-induced systemic lupus erythematosus. , 1986, British journal of rheumatology.
[11] M. Dougados,et al. Influence of oral contraceptive therapy on the activity of systemic lupus erythematosus. , 1982, Arthritis and rheumatism.